Your browser doesn't support javascript.
loading
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.
Przystal, Justyna M; Cianciolo Cosentino, Chiara; Yadavilli, Sridevi; Zhang, Jie; Laternser, Sandra; Bonner, Erin R; Prasad, Rachna; Dawood, Adam A; Lobeto, Nina; Chin Chong, Wai; Biery, Matt C; Myers, Carrie; Olson, James M; Panditharatna, Eshini; Kritzer, Bettina; Mourabit, Sulayman; Vitanza, Nicholas A; Filbin, Mariella G; de Iuliis, Geoffry N; Dun, Matthew D; Koschmann, Carl; Cain, Jason E; Grotzer, Michael A; Waszak, Sebastian M; Mueller, Sabine; Nazarian, Javad.
Affiliation
  • Przystal JM; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Cianciolo Cosentino C; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Yadavilli S; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Zhang J; Research Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA.
  • Laternser S; Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
  • Bonner ER; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Prasad R; Research Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA.
  • Dawood AA; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Lobeto N; Research Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA.
  • Chin Chong W; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Biery MC; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia and Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Myers C; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • Olson JM; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • Panditharatna E; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Kritzer B; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Mourabit S; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Vitanza NA; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Filbin MG; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • de Iuliis GN; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Dun MD; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Koschmann C; Reproductive Science Group, College of Engineering, Science and Environment, University of Newcastle, Callaghan, New South Wales, Australia.
  • Cain JE; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia.
  • Grotzer MA; Department of Pediatrics, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Waszak SM; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia and Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Mueller S; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Nazarian J; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway.
Neuro Oncol ; 24(9): 1438-1451, 2022 09 01.
Article in En | MEDLINE | ID: mdl-35157764
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_energeticas / Bioenergetica Main subject: Glioma / Antineoplastic Agents Language: En Journal: Neuro Oncol Year: 2022 Type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_energeticas / Bioenergetica Main subject: Glioma / Antineoplastic Agents Language: En Journal: Neuro Oncol Year: 2022 Type: Article Affiliation country: Switzerland